Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Schizophrenia

Free Subscription Articles published in Psychol Med Retrieve available abstracts of 166 articles: HTML format

Single Articles

October 2025
1. ZHANG Y, Wang H, Cai M, Wang W, et al
   From risk to chronicity: genetic and neuroimaging insights into the evolving patterns of spontaneous brain activity in schizophrenia.
   Psychol Med. 2025;55:e306.
   PubMed     Abstract available
   
   
   
2. YAO S, Mo F, Rao Z, Shi Y, et al
   Network localization of genetic risk for schizophrenia and bipolar disorder.
   Psychol Med. 2025;55:e299.
   PubMed     Abstract available
   
   
   September 2025
3. LIU KY, Perera G, Howard R, Mueller C, et al
   Cognitive trajectories and dementia risk in patients with schizophrenia spectrum versus affective disorders.
   Psychol Med. 2025;55:e286.
   PubMed     Abstract available
   
   
   
4. MICHALOPOULOU PG, Meshreky KM, Hommerich Z, Shergill SS, et al
   Neuromodulation and neural networks in psychiatric disorders: current status and emerging prospects.
   Psychol Med. 2025;55:e281.
   PubMed     Abstract available
   
   
   
5. BLOOMFIELD M, Modaffar M, Noar A, Walker C, et al
   Brain structure and function in adult survivors of developmental trauma with psychosis: A systematic review.
   Psychol Med. 2025;55:e272.
   PubMed     Abstract available
   
   
   
6. YIN L, Liu M, Shi Y, Zhang R, et al
   Uncovering the genetic underpinnings for different psychiatric disorder combinations.
   Psychol Med. 2025;55:e270.
   PubMed     Abstract available
   
   
   
7. DE BEER F, de Vries E, Wijnen B, Begemann MJH, et al
   Dopamine D(2/3)R availability after discontinuation of antipsychotic treatment: a [(11)C]raclopride PET study in remitted first-episode psychosis patients.
   Psychol Med. 2025;55:e264.
   PubMed     Abstract available
   
   
   
8. ODUOLA S, Pathan S, Hodgekins J, Teague B, et al
   Ethnic disparities, clinical and pathways to care characteristics associated with the offer, uptake, and type of psychological therapy during first-episode psychosis: examining the role of early intervention for psychosis.
   Psychol Med. 2025;55:e262.
   PubMed     Abstract available
   
   
   August 2025
9. SHAO X, Ren H, Dai L, He J, et al
   Progressive gray matter reduction in schizophrenia patients with persistent auditory hallucinations by causal structural covariance network analysis.
   Psychol Med. 2025;55:e255.
   PubMed     Abstract available
   
   
   
10. LIU CI, Liu CM, Hsieh MH, Lin YT, et al
    Successful antipsychotic dose tapering leading to better cognition in patients with remitted psychosis: Results of Guided Antipsychotic Reduction to Reach Minimum Effective Dose (GARMED) trial.
    Psychol Med. 2025;55:e247.
    PubMed     Abstract available
    
    
    
11. MUKHTAR H, Zhou D, Farina EA, Saxena A, et al
    Prediction of antipsychotic medication inception in antipsychotic-naive youth at clinical high risk for psychosis.
    Psychol Med. 2025;55:e241.
    PubMed     Abstract available
    
    
    
12. SUN T, Zhu Y, Zhao P, Zhao W, et al
    Impact of schizophrenia-associated risk genes on brain functional networks and executive deficits: a study of individuals with schizophrenia and genetic high risk.
    Psychol Med. 2025;55:e240.
    PubMed     Abstract available
    
    
    
13. KENDLER KS, Ohlsson H, Sundquist J, Sundquist K, et al
    The outcome of major psychiatric and substance use disorders as an index of genetic risk and genetic heterogeneity.
    Psychol Med. 2025;55:e233.
    PubMed     Abstract available
    
    
    
14. GANNON L, Teague V, Oduola S, McNicholas F, et al
    The proportion of people with a first episode of psychosis admitted to hospital at initial presentation: a systematic review and meta-analysis.
    Psychol Med. 2025;55:e228.
    PubMed     Abstract available
    
    
    
15. SONG Y, Zeng J, Cao H, Cheng B, et al
    Neurofunctional representations of instrumental learning in psychosis: a meta-analysis of neuroimaging studies.
    Psychol Med. 2025;55:e229.
    PubMed     Abstract available
    
    
    
16. LIVINGSTON NR, Kiemes A, O'Daly O, Knight SR, et al
    Diazepam modulates hippocampal CA1 functional connectivity in people at clinical high-risk for psychosis.
    Psychol Med. 2025;55:e230.
    PubMed     Abstract available
    
    
    
17. CUESTA MJ, Gil-Berrozpe GJ, Sanchez-Torres AM, Moreno-Izco L, et al
    Multidimensional outcome of first-episode psychosis: a network analysis - CORRIGENDUM.
    Psychol Med. 2025;55:e222.
    PubMed    
    
    
    July 2025
18. MENA S, Coutts F, von Trott J, Ucur E, et al
    AI-based prediction of depression symptomatology in first-episode psychosis patients: insights from the EUFEST and RAISE-ETP clinical trials.
    Psychol Med. 2025;55:e221.
    PubMed     Abstract available
    
    
    
19. HUANG Y, He J, Zhang X, Chen J, et al
    Leveraging stacked classifiers for exploring the role of hedonic processing between major depressive disorder and schizophrenia.
    Psychol Med. 2025;55:e211.
    PubMed     Abstract available
    
    
    
20. COSTAS-CARRERA A, Verdolini N, Mezquida G, Forte MF, et al
    Obstetric complications, cortical gyrification, and cognition in first-episode psychosis.
    Psychol Med. 2025;55:e209.
    PubMed     Abstract available
    
    
    
21. CONEJEROS-PAVEZ J, Vasquez J, Diaz C, Mena C, et al
    Premorbid school performance trajectories in patients with treatment-resistant schizophrenia prescribed clozapine in the public health system in Chile: a case-control study, 2007-2020.
    Psychol Med. 2025;55:e205.
    PubMed     Abstract available
    
    
    
22. WALTZ JA, Pujji SD, Colloca L
    Placebo and nocebo phenomena in schizophrenia spectrum disorders: a narrative review on current knowledge and potential future directions.
    Psychol Med. 2025;55:e199.
    PubMed     Abstract available
    
    
    
23. HAJNAL A, Csulak T, Hebling D, Farkas Borbasne K, et al
    Spontaneous mentalizing in patients with schizophrenia spectrum disorders: a meta-analysis.
    Psychol Med. 2025;55:e195.
    PubMed     Abstract available
    
    
    June 2025
24. VAN DE WEIJER MP, Liu S, Thijssen AB, Wootton RE, et al
    The causal effect of smoking on psychiatric disorders: an examination of brain volume as a potential pathway.
    Psychol Med. 2025;55:e171.
    PubMed     Abstract available
    
    
    May 2025
25. FLINN A, Hefferman-Clarke R, Parker S, Allsopp K, et al
    Cumulative exposure to childhood adversity and risk of adult psychosis: a dose-response meta-analysis.
    Psychol Med. 2025;55:e162.
    PubMed     Abstract available
    
    
    
26. DRYMONITOU G, McCulloch A, Parry S, Gough R, et al
    The association between disordered eating and psychosis in clinical and non-clinical populations: a systematic review and meta-analysis.
    Psychol Med. 2025;55:e160.
    PubMed     Abstract available
    
    
    
27. FRILIGKOU E, Pathak GA, Tylee DS, De Lillo A, et al
    Characterizing pleiotropy among bipolar disorder, schizophrenia, and major depression: a genome-wide cross-disorder meta-analysis.
    Psychol Med. 2025;55:e145.
    PubMed     Abstract available
    
    
    
28. PIKE B, Ambrosio L, Ellett L
    Brief psychological interventions for schizophrenia: a systematic review and meta-analysis.
    Psychol Med. 2025;55:e146.
    PubMed     Abstract available
    
    
    
29. WADDINGTON JL
    From genetics and cerebral asymmetry, through motor dysfunction intrinsic to psychosis, to early intervention: elaborating the seminal contributions of Timothy J. Crow.
    Psychol Med. 2025;55:e143.
    PubMed    
    
    
    
30. PERALTA V, Moreno-Izco L, Garcia de Jalon E, Sanchez-Torres AM, et al
    Lifetime suicidal thoughts, attempts, and lethality of attempts as major outcome domains of psychotic disorders: a 21-year prospective cohort study after a first-episode psychosis - CORRIGENDUM.
    Psychol Med. 2025;55:e136.
    PubMed    
    
    
    
31. SERIMAA O, Keltikangas-Jarvinen L, Lyytikainen LP, Hietala J, et al
    Polygenic risk for schizophrenia and subjective well-being in a general population sample.
    Psychol Med. 2025;55:e133.
    PubMed     Abstract available
    
    
    April 2025
32. FENG Y, Wong KC, Leung PB, Lee BK, et al
    Longitudinal impact of different treatment sequences of second-generation antipsychotics on metabolic outcomes: a study using targeted maximum likelihood estimation.
    Psychol Med. 2025;55:e123.
    PubMed     Abstract available
    
    
    
33. JEON E, Li L, Le TH, Kim WS, et al
    Virtual reality therapy targeting ideas of reference in patients with psychosis: a single-blind parallel-group randomized controlled trial.
    Psychol Med. 2025;55:e121.
    PubMed     Abstract available
    
    
    
34. CEDERLOF E, Holm M, Kampe A, Ahola-Olli A, et al
    Sleep and schizophrenia polygenic scores in non-affective and affective psychotic disorders.
    Psychol Med. 2025;55:e117.
    PubMed     Abstract available
    
    
    
35. STRAKELJAHN F, Lincoln TM, Schlier B
    Predicting experiences of paranoia and auditory verbal hallucinations in daily life with ambulatory sensor data - A feasibility study.
    Psychol Med. 2025;55:e114.
    PubMed     Abstract available
    
    
    
36. RAMI FZ, Seo H, Kang C, Park S, et al
    Associations of polygenic risk score, environmental factors, and their interactions with the risk of schizophrenia spectrum disorders.
    Psychol Med. 2025;55:e111.
    PubMed     Abstract available
    
    
    
37. CHEN YHE, Wong SMY, So MM, Suen YN, et al
    Spurious autobiographical memories of psychosis: a dopamine-gated neuroplasticity account for relapse and treatment-resistant psychosis.
    Psychol Med. 2025;55:e14.
    PubMed     Abstract available
    
    
    
38. KIESEPPA V, Lang U, Healy C, O'Hare K, et al
    Do psychotic symptoms predict future psychotic disorders in adolescent psychiatry inpatients? A 17-year cohort study.
    Psychol Med. 2025;55:e108.
    PubMed     Abstract available
    
    
    March 2025
39. SIMONSSON O, Goldberg SB, Osika W, Stenfors CUD, et al
    Longitudinal associations of naturalistic psychedelic use with psychotic and manic symptoms.
    Psychol Med. 2025;55:e99.
    PubMed     Abstract available
    
    
    
40. HAN Y, Wang X, Cheng S, Yan P, et al
    Cortical morphometric similarity gradient in schizophrenia and its association with transcriptional profiles and clinical phenotype.
    Psychol Med. 2025;55:e97.
    PubMed     Abstract available
    
    
    
41. UPADHYAYA S, Sucksdorff D, Koskela M, Cheslack-Postava K, et al
    Parental psychiatric disorders and age-specific risk for offspring major depression: Finnish nationwide register-based study.
    Psychol Med. 2025;55:e96.
    PubMed     Abstract available
    
    
    
42. BIRIA M, Banca P, Barnham IJ, Marzuki AA, et al
    Clozapine-induced obsessive-compulsive symptoms in schizophrenia: Clinical and cognitive determinants of dysfunctional checking.
    Psychol Med. 2025;55:e87.
    PubMed     Abstract available
    
    
    
43. SCOTT I, Aarts E, Wannan C, Gao CX, et al
    Characterising symptomatic substates in individuals on the psychosis continuum: a hidden Markov modelling approach.
    Psychol Med. 2025;55:e82.
    PubMed     Abstract available
    
    
    
44. BORREGO-RUIZ A, Borrego JJ
    Involvement of virus infections and antiviral agents in schizophrenia.
    Psychol Med. 2025;55:e73.
    PubMed     Abstract available
    
    
    
45. MULLIGAN LD, Varese F, Harris K, Haddock G, et al
    Cannabis use and suicide in people with a diagnosis of schizophrenia: a systematic review and meta-analysis of longitudinal, case control, and cross-sectional studies.
    Psychol Med. 2025;55:e79.
    PubMed     Abstract available
    
    
    
46. PALANIYAPPAN L, Liddle PF
    Seminal Contributions of Timothy J. Crow.
    Psychol Med. 2025;55:e75.
    PubMed     Abstract available
    
    
    
47. PERALTA V, Moreno-Izco L, de Jalon EG, Sanchez-Torres AM, et al
    Lifetime suicidal thoughts, attempts, and lethality of attempts as major outcome domains of psychotic disorders: a 21-year prospective cohort study after a first-episode psychosis.
    Psychol Med. 2025;55:e69.
    PubMed     Abstract available
    
    
    
48. WATSON AJ, Stringer D, Pickles A, McCrone P, et al
    A network approach exploring the effects of cognitive remediation on cognition, symptoms, and functioning in early psychosis.
    Psychol Med. 2025;55:e66.
    PubMed     Abstract available
    
    
    
49. CAVELTI M, Kaeser JM, Sele S, Berger T, et al
    The relationship between stress and clinical high-risk symptoms of psychosis in daily life: impact of contemporaneous paths on cross-lagged effects.
    Psychol Med. 2025;55:e68.
    PubMed     Abstract available
    
    
    February 2025
50. HEMAGER N, Gjode ICT, Gregersen M, Brandt JM, et al
    Family functioning in families with 11-year-old children at familial high risk of schizophrenia or bipolar disorder and population-based controls: The Danish High Risk and Resilience Study VIA 11.
    Psychol Med. 2025;55:e62.
    PubMed     Abstract available
    
    
    
51. JOO SW, Lee J, Han J, Kim M, et al
    Disparities in accelerated brain aging in recent-onset and chronic schizophrenia.
    Psychol Med. 2025;55:e60.
    PubMed     Abstract available
    
    
    
52. PANAYI P, Contreras A, Peters E, Bentall R, et al
    A temporal network analysis of complex post-traumatic stress disorder and psychosis symptoms.
    Psychol Med. 2025;55:e43.
    PubMed     Abstract available
    
    
    
53. GARCIA-LEON MA, Fuentes-Claramonte P, Gee A, Ramiro-Sousa N, et al
    Are delusions and/or referentiality associated with aberrant reward prediction error (RPE) signaling? Evidence from fMRI using a probabilistic monetary reward task.
    Psychol Med. 2025;55:e55.
    PubMed     Abstract available
    
    
    
54. FREEMAN D, Waite F
    Sleep and circadian difficulties in schizophrenia: presentations, understanding, and treatment.
    Psychol Med. 2025;55:e47.
    PubMed     Abstract available
    
    
    
55. MAXIMO J, Nelson E, Kraguljac N, Patton R, et al
    Changes in glutamate levels in anterior cingulate cortex following 16 weeks of antipsychotic treatment in antipsychotic-naive first-episode psychosis patients.
    Psychol Med. 2025;55:e35.
    PubMed     Abstract available
    
    
    
56. TSAI SJ, Cheng CM, Chang WH, Bai YM, et al
    Panic disorder and suicide.
    Psychol Med. 2025;55:e38.
    PubMed     Abstract available
    
    
    
57. LUTHER L, Raugh IM, Strauss GP
    Probabalistic reinforcement learning impairments predict negative symptom severity and risk for conversion in youth at clinical high-risk for psychosis.
    Psychol Med. 2025;55:e28.
    PubMed     Abstract available
    
    
    
58. CUESTA MJ, Gil-Berrozpe GJ, Sanchez-Torres AM, Moreno-Izco L, et al
    Multidimensional outcome of first-episode psychosis: a network analysis.
    Psychol Med. 2025;55:e29.
    PubMed     Abstract available
    
    
    
59. STRAUSS GP, Raugh I, Visser K, Walker E, et al
    Deconstructing the nature of emotion regulation impairments at the identification, selection, and implementation stages in individuals at clinical high-risk for psychosis.
    Psychol Med. 2025;55:e22.
    PubMed     Abstract available
    
    
    
60. FERRARO L, Di Forti M, La Barbera D, La Cascia C, et al
    Cognitive presentation at psychosis onset through premorbid deterioration and exposure to environmental risk factors.
    Psychol Med. 2025;55:e12.
    PubMed     Abstract available
    
    
    
61. SAPERIA S, Plahouras J, Best M, Kidd S, et al
    The cognitive model of negative symptoms: a systematic review and meta-analysis of the dysfunctional belief systems associated with negative symptoms in schizophrenia spectrum disorders.
    Psychol Med. 2025;55:e11.
    PubMed     Abstract available
    
    
    
62. SARGENT K, Martinez E, Reed A, Guha A, et al
    Brain-body dysconnectivity: deficient autonomic regulation of cortical function in first-episode schizophrenia.
    Psychol Med. 2025;55:e1.
    PubMed     Abstract available
    
    
    January 2025
63. SEE CRZ, Si S, Hedges E, Tognin S, et al
    The effects of recent stressful life events on outcomes in individuals at clinical high risk for psychosis: results from the longitudinal EU-GEI high-risk study.
    Psychol Med. 2025 Jan 8:1-11. doi: 10.1017/S0033291724003039.
    PubMed     Abstract available
    
    
    
64. DAUVERMANN MR, Costello L, Tronchin G, Corley E, et al
    Cellular and extracellular white matter alterations after childhood trauma experience in individuals with schizophrenia.
    Psychol Med. 2025 Jan 6:1-10. doi: 10.1017/S0033291724003064.
    PubMed     Abstract available
    
    
    December 2024
65. PYLE M, Corrigan PW, Wood L, Pilling S, et al
    A feasibility randomized controlled trial of an individually delivered, peer support intervention to reduce the impact of psychosis stigma and discrimination for people with psychosis: the let's talk study.
    Psychol Med. 2024 Dec 27:1-12. doi: 10.1017/S0033291724002605.
    PubMed     Abstract available
    
    
    
66. FARES-OTERO NE, Verdolini N, Melero H, Andres-Camazon P, et al
    Triangulating the associations of different types of childhood adversity and first-episode psychosis with cortical thickness across brain regions.
    Psychol Med. 2024 Dec 16:1-14. doi: 10.1017/S0033291724002393.
    PubMed     Abstract available
    
    
    
67. XU R, Zhang X, Zhou S, Guo L, et al
    Brain structural damage networks at different stages of schizophrenia.
    Psychol Med. 2024 Dec 11:1-11. doi: 10.1017/S0033291724003088.
    PubMed     Abstract available
    
    
    
68. STROMME MF, Thue Augustsson M, Bartz-Johannessen C, Stautland A, et al
    Suicidality and use of psychotropic medications in patients with schizophrenia: a prospective cohort study.
    Psychol Med. 2024 Dec 9:1-9. doi: 10.1017/S0033291724002873.
    PubMed     Abstract available
    
    
    
69. FROST R, Collier O, Hardy A
    Are trauma-related beliefs associated with psychosis symptoms? A systematic review and meta-analysis.
    Psychol Med. 2024 Dec 9:1-10. doi: 10.1017/S0033291724002629.
    PubMed     Abstract available
    
    
    
70. AUSTIN-ZIMMERMAN I, Spinazzola E, Quattrone D, Wu-Choi B, et al
    The impact of schizophrenia genetic load and heavy cannabis use on the risk of psychotic disorder in the EU-GEI case-control and UK Biobank studies.
    Psychol Med. 2024 Dec 6:1-13. doi: 10.1017/S0033291724002058.
    PubMed     Abstract available
    
    
    
71. YEH D, He Q, Krebs E, Iftimovici A, et al
    Cognitive impairment in the schizophrenia spectrum: exploring the relationships of the g-factor with sociodemography, psychopathology, neurodevelopment, and genetics.
    Psychol Med. 2024 Dec 2:1-12. doi: 10.1017/S0033291724002538.
    PubMed     Abstract available
    
    
    
72. YANG KC, Yang BH, Lan CC, Liu MN, et al
    Striatal and peripheral dopaminergic alterations related to cognitive impairment in patients with schizophrenia.
    Psychol Med. 2024 Dec 2:1-11. doi: 10.1017/S0033291724002228.
    PubMed     Abstract available
    
    
    
73. SKLAR AL, Matinrazm S, Esseku A, Lopez-Caballero F, et al
    Longitudinal evaluation of the early auditory gamma-band response and its modulation by attention in first-episode psychosis.
    Psychol Med. 2024 Dec 2:1-9. doi: 10.1017/S0033291724003052.
    PubMed     Abstract available
    
    
    November 2024
74. O'DONOGHUE B, Oliver D, Geros H, Sizer H, et al
    Enriching ultra-high risk for psychosis cohorts based on accumulated exposure to environmental risk factors for psychotic disorders.
    Psychol Med. 2024 Nov 25:1-9. doi: 10.1017/S0033291724002551.
    PubMed     Abstract available
    
    
    
75. ROLDAN L, Sanchez-Gutierrez T, Fernandez-Arias I, Rodriguez-Toscano E, et al
    Cannabis use and cognitive biases in people with first-episode psychosis and their siblings.
    Psychol Med. 2024 Nov 22:1-11. doi: 10.1017/S0033291724001715.
    PubMed     Abstract available
    
    
    
76. YAO G, Luo J, Li J, Feng K, et al
    Functional gradient dysfunction in drug-naive first-episode schizophrenia and its correlation with specific transcriptional patterns and treatment predictions.
    Psychol Med. 2024 Nov 18:1-13. doi: 10.1017/S0033291724001739.
    PubMed     Abstract available
    
    
    
77. HANSEN HG, Speyer H, Sturup AE, Hjorthoj C, et al
    Use and discontinuation of antipsychotic medication in 20 years following a first episode of schizophrenia: results from the OPUS trial.
    Psychol Med. 2024 Nov 18:1-11. doi: 10.1017/S0033291724002678.
    PubMed     Abstract available
    
    
    
78. ROELL L, Fischer T, Keeser D, Papazov B, et al
    Effects of aerobic exercise on hippocampal formation volume in people with schizophrenia - a systematic review and meta-analysis with original data from a randomized-controlled trial.
    Psychol Med. 2024 Nov 18:1-12. doi: 10.1017/S0033291724001867.
    PubMed     Abstract available
    
    
    
79. YANG J, Liu Z, Pan Y, Fan Z, et al
    Regional neural functional efficiency across schizophrenia, bipolar disorder, and major depressive disorder: a transdiagnostic resting-state fMRI study.
    Psychol Med. 2024 Nov 18:1-12. doi: 10.1017/S0033291724001685.
    PubMed     Abstract available
    
    
    October 2024
80. OKUDA T, Kimoto S, Kawabata R, Bian Y, et al
    Alterations in inhibitory neuron subtype-selective transcripts in the prefrontal cortex: comparisons across schizophrenia and mood disorders.
    Psychol Med. 2024 Oct 31:1-10. doi: 10.1017/S0033291724002344.
    PubMed     Abstract available
    
    
    
81. ANTONUCCI LA, Raio A, Kikidis GC, Bertolino A, et al
    Personality changes during adolescence predict young adult psychosis proneness and mediate gene-environment interplays of schizophrenia risk.
    Psychol Med. 2024 Oct 28:1-11. doi: 10.1017/S0033291724002198.
    PubMed     Abstract available
    
    
    
82. IFTIMOVICI A, Krebs E, Dalfin W, Legrand A, et al
    Neurodevelopmental predictors of treatment response in schizophrenia and bipolar disorder.
    Psychol Med. 2024 Oct 15:1-12. doi: 10.1017/S0033291724001776.
    PubMed     Abstract available
    
    
    
83. NOSTDAL A, Hilker R, Halgren C, Speyer H, et al
    Deprescribing antipsychotics in patients with schizophrenia: findings from a specialized clinic.
    Psychol Med. 2024 Oct 15:1-10. doi: 10.1017/S0033291724001910.
    PubMed     Abstract available
    
    
    
84. KERR-GAFFNEY J, Nuerzati Y, Kopra EI, Young AH, et al
    Impulsivity in first-degree relatives at risk of psychosis and mania: a systematic review and meta-analysis.
    Psychol Med. 2024 Oct 14:1-9. doi: 10.1017/S0033291724001752.
    PubMed     Abstract available
    
    
    
85. GOODING P, Harris K, Duxbury P, Pratt D, et al
    Influence of perceived harm due to substance use on the relationships between positive psychotic experiences and suicidal experiences in people with non-affective psychosis.
    Psychol Med. 2024 Oct 4:1-11. doi: 10.1017/S0033291724001764.
    PubMed     Abstract available
    
    
    
86. PANAYI P, Peters E, Bentall R, Hardy A, et al
    Complex PTSD symptoms predict positive symptoms of psychosis in the flow of daily life.
    Psychol Med. 2024 Oct 4:1-12. doi: 10.1017/S0033291724001934.
    PubMed     Abstract available
    
    
    September 2024
87. NKIRE N, Kinsella A, Russell V, Waddington JL, et al
    What is the duration of untreated psychosis worldwide?
    Psychol Med. 2024 Sep 26:1-3. doi: 10.1017/S0033291724002125.
    PubMed    
    
    
    
88. GIBSON LL, Mueller C, Stewart R, Aarsland D, et al
    Characteristics associated with progression to probable dementia with Lewy bodies in a cohort with very late-onset psychosis.
    Psychol Med. 2024 Sep 26:1-10. doi: 10.1017/S0033291724001922.
    PubMed     Abstract available
    
    
    
89. SELTEN JP, Alrashed H, Oh H, Blokland GAM, et al
    Psychosis risk for lesbian, gay, and bisexual individuals: systematic review and meta-analysis.
    Psychol Med. 2024 Sep 25:1-10. doi: 10.1017/S0033291724002253.
    PubMed     Abstract available
    
    
    
90. BRAMNESS JG, Hjorthoj C, Niemela S, Taipale H, et al
    Discussing the concept of substance-induced psychosis (SIP).
    Psychol Med. 2024 Sep 10:1-5. doi: 10.1017/S0033291724001442.
    PubMed     Abstract available
    
    
    
91. GOLAY P, Abrahamyan Empson L, Mebdouhi N, Conchon C, et al
    Statistical implication analysis: a novel approach to understand the reciprocal relationships between outcomes in early psychosis.
    Psychol Med. 2024 Sep 9:1-6. doi: 10.1017/S0033291724001430.
    PubMed     Abstract available
    
    
    
92. KRUGER E, Hall L, Martinez AP, Bentall RP, et al
    Cognitive behavioral self-help interventions for individuals experiencing psychosis: a systematic review.
    Psychol Med. 2024 Sep 9:1-11. doi: 10.1017/S0033291724001545.
    PubMed     Abstract available
    
    
    
93. MARCHAM L, Ellett L
    Exposure to green spaces and schizophrenia: a systematic review.
    Psychol Med. 2024 Sep 9:1-12. doi: 10.1017/S0033291724001533.
    PubMed     Abstract available
    
    
    
94. BORA E, Cesim E, Eyuboglu MS, Demir M, et al
    Effort-based decision-making in ultra-high-risk for psychosis and bipolar disorder.
    Psychol Med. 2024 Sep 6:1-9. doi: 10.1017/S003329172400134.
    PubMed     Abstract available
    
    
    August 2024
95. BAEK JH, Lee D, Lee D, Jeong H, et al
    Exploring intra-diagnosis heterogeneity and inter-diagnosis commonality in genetic architectures of bipolar disorders: association of polygenic risks of major psychiatric illnesses and lifetime phenotype dimensions.
    Psychol Med. 2024;54:3082-3088.
    PubMed     Abstract available
    
    
    July 2024
96. VAN HOOIJDONK CFM, Balvers MGJ, van der Pluijm M, Smith CLC, et al
    Endocannabinoid levels in plasma and neurotransmitters in the brain: a preliminary report on patients with a psychotic disorder and healthy individuals.
    Psychol Med. 2024;54:2189-2199.
    PubMed     Abstract available
    
    
    
97. KENDLER KS, Ohlsson H, Sundquist J, Sundquist K, et al
    The genetic epidemiology of schizotypal personality disorder.
    Psychol Med. 2024;54:2144-2151.
    PubMed     Abstract available
    
    
    June 2024
98. CHEN LG, Tubbs JD, Liu Z, Thach TQ, et al
    Mendelian randomization: causal inference leveraging genetic data.
    Psychol Med. 2024;54:1461-1474.
    PubMed     Abstract available
    
    
    
99. GUIMOND S, Alftieh A, Devenyi GA, Mike L, et al
    Enlarged pituitary gland volume: a possible state rather than trait marker of psychotic disorders.
    Psychol Med. 2024;54:1835-1843.
    PubMed     Abstract available
    
    
    
100. KENDLER KS, Ohlsson H, Sundquist J, Sundquist K, et al
     The predictive effect of family genetic risk scores as an indirect measure of causal effects of one disorder on another.
     Psychol Med. 2024;54:1867-1875.
     PubMed     Abstract available
     
     
     
101. ZHANG Z, Wei W, Wang S, Li M, et al
     Dynamic structure-function coupling across three major psychiatric disorders.
     Psychol Med. 2024;54:1629-1640.
     PubMed     Abstract available
     
     
     
102. ALKEMA A, Marchi M, van der Zaag JAJ, van der Sluis D, et al
     Childhood abuse v. neglect and risk for major psychiatric disorders.
     Psychol Med. 2024;54:1598-1609.
     PubMed     Abstract available
     
     
     May 2024
103. PERALTA V, Garcia de Jalon E, Moreno-Izco L, Peralta D, et al
     The association of adverse childhood experiences with long-term outcomes of psychosis: a 21-year prospective cohort study after a first episode of psychosis.
     Psychol Med. 2024 May 30:1-10. doi: 10.1017/S0033291724001223.
     PubMed     Abstract available
     
     
     
104. MAITRA R, Lemmers-Jansen ILJ, Vooren M, Vanes L, et al
     Understanding the mechanisms underlying cognitive control in psychosis.
     Psychol Med. 2024 May 23:1-10. doi: 10.1017/S0033291724001119.
     PubMed     Abstract available
     
     
     
105. ANDERSON KK, Khan JA, Edwards J, Le B, et al
     Lost in translation? Deciphering the role of language differences in the excess risk of psychosis among migrant groups.
     Psychol Med. 2024 May 22:1-8. doi: 10.1017/S003329172400117.
     PubMed     Abstract available
     
     
     
106. XUE R, Li X, Deng W, Liang C, et al
     Shared and distinct electroencephalogram microstate abnormalities across schizophrenia, bipolar disorder, and depression.
     Psychol Med. 2024 May 13:1-8. doi: 10.1017/S0033291724001132.
     PubMed     Abstract available
     
     
     
107. SELTEN JP, Di Forti M, Quattrone D, Jones PB, et al
     The contribution of cannabis use to the increased psychosis risk among minority ethnic groups in Europe.
     Psychol Med. 2024 May 9:1-10. doi: 10.1017/S0033291724001004.
     PubMed     Abstract available
     
     
     
108. DEMRO C, Lahud E, Burton PC, Purcell JR, et al
     Reward anticipation-related neural activation following cued reinforcement in adults with psychotic psychopathology and biological relatives.
     Psychol Med. 2024;54:1441-1451.
     PubMed     Abstract available
     
     
     April 2024
109. UCOK A, Noyan H, Guloksuz S, Saka MC, et al
     The relationship between childhood trauma, psychotic symptoms, and cognitive schemas in patients with schizophrenia, their siblings, and healthy controls: results from the EU-GEI study.
     Psychol Med. 2024 Apr 12:1-12. doi: 10.1017/S0033291724000540.
     PubMed     Abstract available
     
     
     
110. MOLINA JL, Joshi YB, Nungaray JA, Sprock J, et al
     Early auditory processing abnormalities alter individual learning trajectories and sensitivity to computerized cognitive training in schizophrenia.
     Psychol Med. 2024 Apr 8:1-8. doi: 10.1017/S0033291724000783.
     PubMed     Abstract available
     
     
     
111. HJORTHOJ C, Sturup A, Karlsen M, Speyer H, et al
     Use of antipsychotic medication, benzodiazepines, and psychiatric hospitalization in cannabis-related versus cannabis-unrelated schizophrenia - a nationwide, register-based cohort study.
     Psychol Med. 2024 Apr 4:1-10. doi: 10.1017/S0033291724000758.
     PubMed     Abstract available
     
     
     
112. JORGENSEN KN, Nerland S, Slapo NB, Norbom LB, et al
     Assessing regional intracortical myelination in schizophrenia spectrum and bipolar disorders using the optimized T1w/T2w-ratio.
     Psychol Med. 2024 Apr 2:1-11. doi: 10.1017/S0033291724000503.
     PubMed     Abstract available
     
     
     
113. HANSEN HG, Gjode ICT, Starzer M, Ranning A, et al
     Clinical illness course and family-related outcomes among parents with a first episode of schizophrenia spectrum disorder: a 20-year follow-up of the OPUS trial.
     Psychol Med. 2024 Apr 2:1-10. doi: 10.1017/S0033291724000680.
     PubMed     Abstract available
     
     
     
114. WANG J, Luo GY, Tian T, Zhao YQ, et al
     Shared genetic basis and causality between schizophrenia and inflammatory bowel disease: evidence from a comprehensive genetic analysis.
     Psychol Med. 2024 Apr 2:1-11. doi: 10.1017/S0033291724000771.
     PubMed     Abstract available
     
     
     
115. MARCO-GARCIA S, Ariyo K, Owen GS, David AS, et al
     Decision making capacity for treatment in psychiatric inpatients: a systematic review and meta-analysis.
     Psychol Med. 2024;54:1074-1083.
     PubMed     Abstract available
     
     
     
116. LAWRENCE JM, Breunig S, Foote IF, Tallis CB, et al
     Genomic SEM applied to explore etiological divergences in bipolar subtypes.
     Psychol Med. 2024;54:1152-1159.
     PubMed     Abstract available
     
     
     March 2024
117. DENG L, Wei W, Qiao C, Yin Y, et al
     Dynamic aberrances of substantia nigra-relevant coactivation patterns in first-episode treatment-naive patients with schizophrenia.
     Psychol Med. 2024 Mar 25:1-11. doi: 10.1017/S0033291724000655.
     PubMed     Abstract available
     
     
     
118. MELVILLE G, Hoffman M, Pollock A, Kurtz MM, et al
     Do metacognitive therapies for schizophrenia-spectrum disorders work? A meta-analytic investigation.
     Psychol Med. 2024 Mar 21:1-9. doi: 10.1017/S0033291724000564.
     PubMed     Abstract available
     
     
     
119. CUESTA MJ, Garcia de Jalon E, Sanchez-Torres AM, Gil-Berrozpe GJ, et al
     Additive effects of a family history of schizophrenia spectrum disorders and an environmental risk score for the outcome of patients with non-affective first-episode psychosis.
     Psychol Med. 2024 Mar 20:1-9. doi: 10.1017/S0033291724000576.
     PubMed     Abstract available
     
     
     
120. LUO C, Pi X, Zhang Q, Hu N, et al
     A subtype of schizophrenia patients with altered methylation level of genes related to immune cell activity.
     Psychol Med. 2024 Mar 20:1-9. doi: 10.1017/S0033291724000667.
     PubMed     Abstract available
     
     
     
121. FORMICA MJC, Fuller-Tyszkiewicz M, Reininghaus U, Kempton M, et al
     Associations between disturbed sleep and attenuated psychotic experiences in people at clinical high risk for psychosis.
     Psychol Med. 2024 Mar 7:1-10. doi: 10.1017/S0033291724000400.
     PubMed     Abstract available
     
     
     
122. LIU Y, Ren H, Zhang Y, Deng W, et al
     Temporal changes in brain morphology related to inflammation and schizophrenia: an omnigenic Mendelian randomization study.
     Psychol Med. 2024 Mar 6:1-9. doi: 10.1017/S003329172400014.
     PubMed     Abstract available
     
     
     
123. BARNES-SCHEUFLER CV, Rosler L, Schaum M, Schiweck C, et al
     External cues improve visual working memory encoding in the presence of salient distractors in schizophrenia.
     Psychol Med. 2024 Mar 4:1-10. doi: 10.1017/S0033291724000059.
     PubMed     Abstract available
     
     
     
124. ZHANG T, Cui H, Tang X, Xu L, et al
     Models of mild cognitive deficits in risk assessment in early psychosis.
     Psychol Med. 2024 Mar 4:1-12. doi: 10.1017/S0033291724000382.
     PubMed     Abstract available
     
     
     
125. ROBINSON N, Ploner A, Leone M, Lichtenstein P, et al
     Environmental risk factors for schizophrenia and bipolar disorder from childhood to diagnosis: a Swedish nested case-control study.
     Psychol Med. 2024 Mar 1:1-10. doi: 10.1017/S0033291724000266.
     PubMed     Abstract available
     
     
     February 2024
126. CORSI-ZUELLI F, Quattrone D, Ragazzi TCC, Loureiro CM, et al
     Transdiagnostic dimensions of symptoms and experiences associated with immune proteins in the continuity of psychosis.
     Psychol Med. 2024 Feb 28:1-13. doi: 10.1017/S0033291724000199.
     PubMed     Abstract available
     
     
     
127. SIMONSEN C, Asbo G, Slade M, Wold KF, et al
     A good life with psychosis: rate of positive outcomes in first-episode psychosis at 10-year follow-up.
     Psychol Med. 2024 Feb 23:1-10. doi: 10.1017/S0033291724000205.
     PubMed     Abstract available
     
     
     
128. LI X, Vaessen T, Lafit G, van Aubel E, et al
     Higher emotion regulation flexibility predicts more stable negative emotions and faster affective recovery in early psychosis: an experience sampling study.
     Psychol Med. 2024 Feb 12:1-10. doi: 10.1017/S0033291724000151.
     PubMed     Abstract available
     
     
     
129. STARZER M, Hansen HG, Hjorthoj C, Albert N, et al
     20-year neurocognitive development following a schizophrenia spectrum disorder and associations with symptom severity and functional outcomes.
     Psychol Med. 2024 Feb 12:1-11. doi: 10.1017/S0033291724000096.
     PubMed     Abstract available
     
     
     
130. GREEN MF, Wynn JK, Eisenberger NI, Horan WP, et al
     Social cognition and social motivation in schizophrenia and bipolar disorder: are impairments linked to the disorder or to being socially isolated?
     Psychol Med. 2024 Feb 5:1-9. doi: 10.1017/S0033291724000102.
     PubMed     Abstract available
     
     
     
131. TORO VD, Antonucci LA, Quarto T, Passiatore R, et al
     The interaction between early life complications and a polygenic risk score for schizophrenia is associated with brain activity during emotion processing in healthy participants.
     Psychol Med. 2024 Feb 2:1-10. doi: 10.1017/S0033291724000011.
     PubMed     Abstract available
     
     
     January 2024
132. D'ANDREA G, Quattrone D, Malone K, Tripoli G, et al
     Variation of subclinical psychosis across 16 sites in Europe and Brazil: findings from the multi-national EU-GEI study.
     Psychol Med. 2024 Jan 30:1-14. doi: 10.1017/S0033291723003781.
     PubMed     Abstract available
     
     
     
133. ABPLANALP SJ, Braff DL, Light GA, Joshi YB, et al
     Clarifying directional dependence among measures of early auditory processing and cognition in schizophrenia: leveraging Gaussian graphical models and Bayesian networks.
     Psychol Med. 2024 Jan 30:1-10. doi: 10.1017/S0033291724000023.
     PubMed     Abstract available
     
     
     
134. KORTE KJ, Jaguga F, Kim HH, Stroud RE, et al
     Psychometric Properties of the Mini International Neuropsychiatric Interview (MINI) Psychosis Module: A Sub-Saharan Africa Cross Country Comparison - CORRIGENDUM.
     Psychol Med. 2024 Jan 10:1. doi: 10.1017/S0033291723003835.
     PubMed    
     
     
     
135. AKCAOGLU Z, Vaessen T, Velthorst E, Lafit G, et al
     The temporal association between social isolation, distress, and psychotic experiences in individuals at clinical high-risk for psychosis.
     Psychol Med. 2024 Jan 5:1-9. doi: 10.1017/S0033291723003598.
     PubMed     Abstract available
     
     
     
136. BUCHWALD K, Narayanan A, Siegert RJ, Vignes M, et al
     Centrality statistics of symptom networks of schizophrenia: a systematic review.
     Psychol Med. 2024 Jan 4:1-13. doi: 10.1017/S003329172300363.
     PubMed     Abstract available
     
     
     
137. DENG F, Bueber MA, Cao Y, Tang J, et al
     Assessing social cognition in patients with schizophrenia and healthy controls using the reading the mind in the eyes test (RMET): a systematic review and meta-regression.
     Psychol Med. 2024 Jan 4:1-27. doi: 10.1017/S0033291723003501.
     PubMed     Abstract available
     
     
     
138. KENDLER KS, Keefe RSE, Ohlsson H, Sundquist J, et al
     Risk for psychiatric and substance use disorders as a function of transitions in Sweden's public educational system: a national study.
     Psychol Med. 2024;54:117-124.
     PubMed     Abstract available
     
     
     December 2023
139. SALAZAR DE PABLO G, Aymerich C, Guinart D, Catalan A, et al
     What is the duration of untreated psychosis worldwide? - A meta-analysis of pooled mean and median time and regional trends and other correlates across 369 studies.
     Psychol Med. 2023 Dec 13:1-11. doi: 10.1017/S0033291723003458.
     PubMed     Abstract available
     
     
     
140. SAARINEN A, Hietala J, Lyytikainen LP, Hamal Mishra B, et al
     Polygenic risk for schizophrenia predicting social trajectories in a general population sample.
     Psychol Med. 2023 Dec 4:1-9. doi: 10.1017/S003329172300346.
     PubMed     Abstract available
     
     
     
141. POULOS J, Normand ST, Zelevinsky K, Newcomer JW, et al
     Antipsychotics and the risk of diabetes and death among adults with serious mental illnesses.
     Psychol Med. 2023;53:7677-7684.
     PubMed     Abstract available
     
     
     November 2023
142. COSTAS-CARRERA A, Verdolini N, Garcia-Rizo C, Mezquida G, et al
     Difficulties during delivery, brain ventricle enlargement and cognitive impairment in first episode psychosis.
     Psychol Med. 2023 Nov 28:1-11. doi: 10.1017/S0033291723003185.
     PubMed     Abstract available
     
     
     
143. WANG B, Otten LJ, Schulze K, Afrah H, et al
     Is auditory processing measured by the N100 an endophenotype for psychosis? A family study and a meta-analysis.
     Psychol Med. 2023 Nov 24:1-14. doi: 10.1017/S0033291723003409.
     PubMed     Abstract available
     
     
     
144. DI PRINZIO P, Morgan VA
     Early Adversity Scale for Schizophrenia (Short Form) (EAS-Sz (SF)).
     Psychol Med. 2023 Nov 23:1-3. doi: 10.1017/S0033291723003379.
     PubMed    
     
     
     
145. PERALTA D, Janda L, Garcia de Jalon E, Moreno-Izco L, et al
     Long-term diagnostic stability, predictors of diagnostic change, and time until diagnostic change of first-episode psychosis: a 21-year follow-up study.
     Psychol Med. 2023 Nov 21:1-10. doi: 10.1017/S0033291723003173.
     PubMed     Abstract available
     
     
     
146. MARTIN MC
     Correspondence to Freeman et al. (2023)'s virtual reality (VR) therapy for patients with psychosis: satisfaction and side effects.
     Psychol Med. 2023 Nov 6:1-2. doi: 10.1017/S0033291723003100.
     PubMed    
     
     
     
147. LIVINGSTON NR, Fusar-Poli P, Modinos G
     Letter to the Editor on 'Baseline benzodiazepine exposure is associated with greater risk of transition in clinical high-risk for psychosis (CHR-P): a meta-analysis'.
     Psychol Med. 2023 Nov 3:1-2. doi: 10.1017/S0033291723003203.
     PubMed    
     
     
     
148. TROTTA G, Rodriguez V, Quattrone D, Spinazzola E, et al
     Cannabis use as a potential mediator between childhood adversity and first-episode psychosis: results from the EU-GEI case-control study.
     Psychol Med. 2023;53:7375-7384.
     PubMed     Abstract available
     
     
     
149. JAYASINGHE A, Wrobel A, Filia K, Byrne LK, et al
     Distress, burden, and wellbeing in siblings of people with mental illness: a mixed studies systematic review and meta-analysis.
     Psychol Med. 2023;53:6945-6964.
     PubMed     Abstract available
     
     
     October 2023
150. VARESE F, Sellwood W, Pulford D, Awenat Y, et al
     Trauma-focused therapy in early psychosis: results of a feasibility randomized controlled trial of EMDR for psychosis (EMDRp) in early intervention settings.
     Psychol Med. 2023 Oct 26:1-12. doi: 10.1017/S0033291723002532.
     PubMed     Abstract available
     
     
     
151. KAPLER S, Adery L, Hoftman GD, Amir CM, et al
     Assessing evidence supporting cannabis harm reduction practices for adolescents at clinical high-risk for psychosis: a review and clinical implementation tool.
     Psychol Med. 2023 Oct 26:1-11. doi: 10.1017/S0033291723002994.
     PubMed     Abstract available
     
     
     
152. PETKARI E, Nikolaou E, Oberleiter S, Priebe S, et al
     Which psychological interventions improve quality of life in patients with schizophrenia-spectrum disorders? A meta-analysis of randomized controlled trials.
     Psychol Med. 2023 Oct 20:1-24. doi: 10.1017/S0033291723003070.
     PubMed     Abstract available
     
     
     
153. DAVIES C, Bossong MG, Martins D, Wilson R, et al
     Increased hippocampal blood flow in people at clinical high risk for psychosis and effects of cannabidiol.
     Psychol Med. 2023 Oct 17:1-11. doi: 10.1017/S0033291723002775.
     PubMed     Abstract available
     
     
     
154. MULLIGAN LD, Varese F, Harris K, Haddock G, et al
     Alcohol use and suicide-related outcomes in people with a diagnosis of schizophrenia: a comprehensive systematic review and meta-analysis.
     Psychol Med. 2023 Oct 11:1-12. doi: 10.1017/S0033291723002738.
     PubMed     Abstract available
     
     
     
155. VENTURA J, Subotnik KL, Han S, Hellemann GS, et al
     The relationship between sex and functional outcome in first-episode schizophrenia: the role of premorbid adjustment and insight.
     Psychol Med. 2023;53:6878-6887.
     PubMed     Abstract available
     
     
     
156. CAMPBELL-SILLS L, Papini S, Norman SB, Choi KW, et al
     Associations of polygenic risk scores with posttraumatic stress symptom trajectories following combat deployment.
     Psychol Med. 2023;53:6733-6742.
     PubMed     Abstract available
     
     
     
157. HAN S, Xue K, Chen Y, Xu Y, et al
     Identification of shared and distinct patterns of brain network abnormality across mental disorders through individualized structural covariance network analysis.
     Psychol Med. 2023;53:6780-6791.
     PubMed     Abstract available
     
     
     September 2023
158. YAU KC, Revill G, Blackman G, Shaikh M, et al
     Pediatric traumatic brain injury as a risk factor for psychosis and psychotic symptoms: a systematic review and meta-analysis.
     Psychol Med. 2023 Sep 29:1-9. doi: 10.1017/S0033291723002878.
     PubMed     Abstract available
     
     
     
159. HOTTE-MEUNIER A, Penney D, Mendelson D, Thibaudeau E, et al
     Effects of metacognitive training (MCT) on social cognition for schizophrenia spectrum and related psychotic disorders: a systematic review and meta-analysis.
     Psychol Med. 2023 Sep 29:1-7. doi: 10.1017/S0033291723002611.
     PubMed     Abstract available
     
     
     
160. GOH KK, Kanahara N, Chiu YH, Lu ML, et al
     The impact of childhood trauma exposure on social functioning in schizophrenia: the moderated mediation role of oxytocin and oxytocin receptor gene polymorphisms.
     Psychol Med. 2023 Sep 18:1-13. doi: 10.1017/S003329172300274.
     PubMed     Abstract available
     
     
     
161. BIAGGI A, Hazelgrove K, Waites F, Bind RH, et al
     Mother-infant interaction and infant development in women at risk of postpartum psychosis with and without a postpartum relapse.
     Psychol Med. 2023 Sep 14:1-12. doi: 10.1017/S0033291723002568.
     PubMed     Abstract available
     
     
     
162. DONALDSON KR, Jonas K, Foti D, Larsen EM, et al
     Mismatch negativity and clinical trajectories in psychotic disorders: Five-year stability and predictive utility.
     Psychol Med. 2023;53:5818-5828.
     PubMed     Abstract available
     
     
     
163. HAVERS L, von Stumm S, Cardno AG, Freeman D, et al
     Psychotic experiences and negative symptoms from adolescence to emerging adulthood: developmental trajectories and associations with polygenic scores and childhood characteristics.
     Psychol Med. 2023;53:5685-5697.
     PubMed     Abstract available
     
     
     July 2023
164. SEGURA AG, Mezquida G, Martinez-Pinteno A, Gasso P, et al
     Link between cognitive polygenic risk scores and clinical progression after a first-psychotic episode.
     Psychol Med. 2023;53:4634-4647.
     PubMed     Abstract available
     
     
     
165. MA R, Romano E, Ashworth M, Yadegarfar ME, et al
     Multimorbidity clusters among people with serious mental illness: a representative primary and secondary data linkage cohort study.
     Psychol Med. 2023;53:4333-4344.
     PubMed     Abstract available
     
     
     
166. SHUNKAI L, Chen P, Zhong S, Chen G, et al
     Alterations of insular dynamic functional connectivity and psychological characteristics in unmedicated bipolar depression patients with a recent suicide attempt.
     Psychol Med. 2023;53:3837-3848.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Schizophrenia is free of charge.